课题基金 / 基金详情

CCN2 action in fibrosis: Cellular and molecular mechanisms

CCN2 action in fibrosis: Cellular and molecular mechanisms
CCN2 在纤维化中的作用:细胞和分子机制
批准号:
303277
负责人:
Leask Andrew C
金额:
$57.17万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-03-01 至 2019-03-01

项目摘要

项目成果

Leask Andrew C的其他基金

相似基金

相关文献

中文摘要
翻译
包括硬皮病(系统性硬化症)在内的纤维化疾病的特征在于导致器官衰竭的过度瘢痕形成,占发达国家死亡和医疗保健费用的约45%。这种疾病没有治疗方法,
英文摘要
Fibrotic diseases including scleroderma (systemic sclerosis) are characterized by excessive scarring resulting in organ failure and amounts to ~45% of the deaths and health care costs in the developed world. There is no treatment for this diseases as the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The contribution of CCN proteins to scleroderma fibrosis: cellular and molecular mechanisms
  • 批准号:
    460121
  • 项目类别:
    Operating Grants
  • 资助金额:
    $76.07万
  • 财政年份:
    2022
  • 负责人:
    Leask Andrew C
  • 依托单位:
The contribution of CCN proteins to scleroderma fibrosis: cellular and molecular mechanisms
  • 批准号:
    456411
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Leask Andrew C
  • 依托单位:
CCN3: a novel antifibrotic treatment?
  • 批准号:
    336655
  • 项目类别:
    Operating Grants
  • 资助金额:
    $20.02万
  • 财政年份:
    2015
  • 负责人:
    Leask Andrew C
  • 依托单位:
Interntl. Congress on Matricellular Proteins: New Targets for Cancer and Connective Tissue Disease
  • 批准号:
    224166
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.36万
  • 财政年份:
    2011
  • 负责人:
    Leask Andrew C
  • 依托单位:
海外基金